ST Pharm Co Ltd Sustainability Reports
ST Pharm Co., Ltd. operates as a technology-driven contract development and manufacturing organization (CDMO) specializing in gene therapies, messenger RNA (mRNA), and oligonucleotide active pharmaceutical ingredients (APIs). The company provides custom manufacturing and development services from early preclinical stages to commercial scale production.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSDAQ)
FIGI: BBG00BBNGQN2
5 reports from 2024 to 2026